CNBC’s Meg Tirrell talks about the health care IPO market heating up.
For recent and past articles use the menu or tap here.
- The Wall Street Journal: Gilead shares rise after FDA approves cell-therapy drug YescartaGilead’s purchase of Kite Pharma poised to pay offGilead Sciences ... read more6 hours ago
- Drugs@FDA Data FilesDrugs@FDA Downloadable Data File in ZIP format, Data Definitions, and ... read more15 hours ago
- Relievant Medsystems Names Ray M. Baker, M.D. as Chief Medical OfficerDr. Baker will be an integral part of the executive ... read more1 day ago
- Ignyta Stock Booms on Promising Mid-Stage Lung Cancer DataThe good news led Ignyta's stock to jump about five ... read more1 day ago
- Greensboro Firm Inks Deal to Bring Smartphone-Based Fertility Test to Animal BreedingBy Allan Maurer, NCBiotech Writer ... read more2 days ago
- Transplant Tailwinds and MomentumWe've Moved! Update your Reader Now.This feed has moved to: ... read more3 days ago
- Seattle’s PhaseRx Cuts 50% of Employees, Including Some Exec OfficersPhaseRx Announces Corporate Restructuring and Review of Strategic AlternativesSEATTLE, Oct. ... read more6 days ago
- CRISPR Awarded Grant From To Collaborate With University of Alabama at Birmingham On Gene-Edited Treatments For Friedrich???s Ataxia-FARA and CRISPR Celebrate Annual rideATAXIA Event- ZUG, Switzerland and ... read more6 days ago
- UC Santa Cruz student Saloni Gupta earns Sutter scholarship for medical schoolSaloni Gupta, a senior studying human biology, was awarded the ... read more3 weeks ago
To access all our news feeds tap “Headlines“.